Cas no 26086-49-7 (Desoxymycin)
Desoxymycin Chemical and Physical Properties
Names and Identifiers
-
- 4-O-[2-O-[2-(Methylamino)-2-deoxy-α-L-glucopyranosyl]-3,5-dideoxy-3-hydroxymethyl-α-L-arabinofuranosyl]-N,N'-bis(aminoiminomethyl)-D-streptamine
- 1,1'-[(1R,2R,3S,4R,5R,6S)-4-({3,5-Dideoxy-2-O-[2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl]-3-(hydroxymethyl)-alpha-L-arabinofuranosyl}oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine
- 2)-O-3,5-dideoxy-3-(hydroxymethyl)-a-L-arabinofuranosyl-(1&
- 2)-O-3,5-dideoxy-3-(hydroxymethyl)-a-L-arabinofuranosyl-(1®
- 4)-N,N'-bis(aminoiminomethyl)-
- Dihydrodeoxystreptomycin
- D-Streptamine,O-2-deoxy-2-(methylamino)-a-L-glucopyranosyl-(1®
- guanidine, N,N'''-[(1R,2R,3S,4R,5R,6S)-4-[[3,5-dideoxy-2-O-[2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl]-3-(hydroxymethyl)-alpha-L-arabinofuranosyl]oxy]-2,5,6-trihydroxy-1,3-cyclohexanediyl]bis-
- Mervastrep
- Desoxymycin
- UNII-6B6534650A
- Streptamine, O-2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1-2)-O-3,5-dideoxy-3-(hydroxymethyl)-alpha-L-arabinofuranosyl-(1-4)-N,N'-diamidino-, D-
- Diidrodesossistreptomicina
- Q27264443
- 2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2S,3R,4S,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine
- 3'-Deoxydihydrostreptomycin
- 26086-49-7
- 6B6534650A
- DEOXYDIHYDROSTREPTOMYCIN [MI]
- Diidrodesossistreptomicina [Italian]
- BRN 0073560
- Mervastrept
- STREPTAMINE, O-2-DEOXY-2-(METHYLAMINO)-.ALPHA.-L-GLUCOPYRANOSYL-(1-2)-O-3,5-DIDEOXY-3-(HYDROXYMETHYL)-.ALPHA.-L-ARABINOFURANOSYL-(1-4)-N,N'-DIAMIDINO-, D-
- DIHYDROSTREPTOMYCIN SULFATE IMPURITY D [EP IMPURITY]
- DTXSID90948962
- 2-[(1S,2R,3R,4S,5R,6R)-2-[(2S,3R,4S,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)tetrahydropyran-2-yl]oxy-4-(hydroxymethyl)-5-methyl-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine
- CHEBI:135831
- Deoxydihydrostreptomycin
- C03755
- N,N'-[4-({3,5-Dideoxy-2-O-[2-deoxy-2-(methylamino)hexopyranosyl]-3-(hydroxymethyl)pentofuranosyl}oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine
- SCHEMBL564263
- STREPTOMYCIN, DEOXYDIHYDRO-
- 4-18-00-07537 (Beilstein Handbook Reference)
- SureCN564263
- Dihydrodesoxystreptomycin
-
- Inchi： 1S/C21H41N7O11/c1-5-6(3-29)16(38-18-10(26-2)14(34)11(31)7(4-30)37-18)19(36-5)39-17-9(28-21(24)25)12(32)8(27-20(22)23)13(33)15(17)35/h5-19,26,29-35H,3-4H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16+,17+,18-,19-/m0/s1
- InChI Key： RUQATQQNXCPTLL-PQMJGINDSA-N
- SMILES： O([C@H]1[C@@H]([C@@H](CO)[C@H](C)O1)O[C@H]1[C@H]([C@@H]([C@H]([C@H](CO)O1)O)O)NC)[C@H]1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1/N=C(\N)/N)O)/N=C(\N)/N)O)O
Computed Properties
- Exact Mass: 567.286
- Monoisotopic Mass: 567.286
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 12
- Hydrogen Bond Acceptor Count: 14
- Heavy Atom Count: 39
- Rotatable Bond Count: 9
- Complexity: 864
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 15
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 319A^2
- XLogP3: -7.1
Experimental Properties
- Density: 1.951
- Boiling Point: 907.833°C at 760 mmHg
- Flash Point: 502.839°C
- Refractive Index: 1.76
- Specific Rotation: D20 -102.5° (water)
Desoxymycin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D356535-25mg |
Desoxymycin |
26086-49-7 | 25mg |
$155.00 | 2023-05-18 | ||
| TRC | D356535-100mg |
Desoxymycin |
26086-49-7 | 100mg |
$563.00 | 2023-05-18 | ||
| TRC | D356535-250mg |
Desoxymycin |
26086-49-7 | 250mg |
$ 1200.00 | 2023-09-07 |
Additional information on Desoxymycin
Exploring Desoxymycin (CAS No. 26086-49-7): A Comprehensive Overview of Its Properties and Applications
Desoxymycin (CAS No. 26086-49-7) is a specialized compound that has garnered significant attention in the fields of biochemistry and pharmaceuticals. Known for its unique structural properties, this molecule is often studied for its potential applications in antibiotic research and microbial inhibition. The growing interest in novel antimicrobial agents has made Desoxymycin a subject of intense scientific scrutiny, particularly in the context of rising antibiotic resistance.
The chemical structure of Desoxymycin (CAS No. 26086-49-7) features a distinctive arrangement of functional groups that contribute to its biological activity. Researchers have explored its mechanism of action, which often involves targeting bacterial cell walls or disrupting protein synthesis. These properties align with current trends in drug discovery, where scientists are actively seeking compounds that can address multidrug-resistant pathogens. As such, Desoxymycin is frequently mentioned in discussions about next-generation antibiotics.
In addition to its potential therapeutic uses, Desoxymycin (CAS No. 26086-49-7) is also valued for its role in laboratory research. Its stability and solubility make it a reliable candidate for in vitro studies, particularly in assays designed to evaluate antimicrobial efficacy. This versatility has led to its inclusion in various high-throughput screening programs, where it serves as a reference compound for comparing new drug candidates.
The synthesis of Desoxymycin (CAS No. 26086-49-7) involves a series of carefully controlled chemical reactions, often requiring specialized reagents and catalytic conditions. Recent advancements in green chemistry have prompted researchers to explore more sustainable methods for producing this compound, reducing environmental impact while maintaining high yields. This aligns with broader industry efforts to adopt eco-friendly synthesis practices.
From a commercial perspective, Desoxymycin (CAS No. 26086-49-7) is available through select chemical suppliers and research catalogs. Its pricing and availability can vary depending on factors such as purity, quantity, and regional demand. For those seeking detailed technical specifications or safety data sheets, it is advisable to consult reputable sources to ensure compliance with laboratory safety standards.
Looking ahead, the future of Desoxymycin (CAS No. 26086-49-7) appears promising, with ongoing studies exploring its potential in combination therapies and synergistic drug formulations. As the scientific community continues to confront challenges like antimicrobial resistance and emerging infectious diseases, compounds like Desoxymycin will likely remain at the forefront of innovative research.
26086-49-7 (Desoxymycin) Related Products
- 128-46-1(N-(1R,2R,3S,4R,5R,6S)-3-carbamimidamido-4-{(2R,3R,4R,5S)-3-{(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yloxy}-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yloxy}-2,5,6-trihydroxycyclohexylguanidine)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
